Control Bionics Limited (ASX:CBL)

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
United States	4.96M
United States Growth	1.52%
Australia	1.09M
Australia Growth	-11.42%
Research and Development	952.13K
Research and Development Growth	130.65%
International	59.95K
International Growth	314.59%
Corporate Segment	-705.89K
Corporate Segment Growth	64.92%
Australia	1.09M
Australia Growth	-11.42%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Year Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Australia	1.04M
Australia Growth	-15.11%
North America	4.25M
North America Growth	-3.76%
Australia	1.04M
Australia Growth	-15.11%
Other	59.95K